Status:
ENROLLING_BY_INVITATION
Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting
Lead Sponsor:
Truway Health, Inc.
Conditions:
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communi...
Detailed Description
This exploratory, randomized, double-blind, parallel-assignment Phase I/II trial is designed to evaluate the safety, tolerability, and biological activity of low-frequency electromagnetic resonance (L...
Eligibility Criteria
Inclusion
- Male or female participants aged 18-70 years.
- Clinical diagnosis of a systemic autoimmune disorder (e.g., systemic lupus erythematosus, rheumatoid arthritis, or multiple sclerosis) confirmed for at least 12 months.
- Stable disease-modifying therapy or corticosteroid regimen for at least 8 weeks prior to enrollment.
- Willingness to maintain current medication schedule for the duration of the study.
- Ability to provide written informed consent and comply with study procedures.
- Access to stable internet or smartphone connection for digital consent verification and symptom tracking.
Exclusion
- Presence of an implanted medical or electronic device (e.g., pacemaker, defibrillator, deep brain stimulator).
- Pregnancy or lactation.
- Active infection, malignancy, or significant hepatic, renal, or cardiovascular disease.
- Known photosensitivity, seizure disorder, or history of uncontrolled epilepsy.
- Prior participation in any electromagnetic or quantum resonance study within the past 6 months.
- Use of biologic or investigational therapy initiated within the previous 3 months.
- Inability to attend at least 80% of treatment sessions or follow-up visits.
Key Trial Info
Start Date :
October 23 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 23 2034
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07221565
Start Date
October 23 2025
End Date
October 23 2034
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)
New York, New York, United States, 10016